Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
General Information
Revision date
2007-01-05
Product name
Zanosar
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: Sterile, freeze-dried powder pale yellow
Signal word
WARNING
Hazard statements
Possible carcinogen and mutagen May cause reproductive system effects May cause harm to the unborn child. May cause adverse effects on blood forming organs Can cause gastrointestinal and kidney effects
Additional information
Short Term: May cause skin irritation. Not a skin sensitizer (based on components) Effects of ingestion are not known. Avoid swallowing this material. Known Clinical Effects: Adverse effects most commonly reported in clinical use include nausea, vomiting. Kidney dysfunction has been seen during clinical use. Effects on blood and blood-forming organs have also occurred. EU Indication of danger: Carcinogenic: Category 2 Mutagenic Category 2 Toxic to Reproduction; Category 3 EU Hazard Symbols: EU Risk Phrases: R45 - May cause cancer. R46 - May cause heritable genetic damage. R62 - Possible risk of impaired fertility. R63 - Possible risk of harm to the unborn child. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.